Research Grade Lesofavumab
Lesofavumab is a Recombinant monoclonal antibody to Influenza B virus hemagglutinin. Lesofavumab is a human monoclonal antibody that can be potentially used in the treatment of Influenza B infection. Genentech, a subsidiary of Roche, is developing lesofavumab (RG 6024), a monoclonal antibody, for the treatment of influenza B infections.
Product Specifications
Product Name Alternative
RG6024, RG 6024, MHAB5553A, RG70026, RO7045557, CAS: 1807960-57-1
Accession Number
P03461
Expression System
Mammalian Cells
Reactivity
Influenza B virus
Applications
Research Grade Biosimilar
Stability
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks) . Store at -20°C 12 months. Store at -80°C long term.
Endotoxin
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Form
Liquid
Buffer
0.01M PBS, pH 7.4.
Notes
For research use only. Not suitable for clinical or therapeutic use.
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
AS10 1013 1 mg
Goat anti-Human IgE (epsilon chain), TRITC conjugated, min, cross-reactivity to bovine, mouse, rabbit serum
Ask
View Details 
MBS1456589-01 0.02 mg (E-Coli)
Recombinant Human Syntaxin-binding protein 2 (STXBP2)
Ask
View Details 
MBS1456589-02 0.02 mg (Yeast)
Recombinant Human Syntaxin-binding protein 2 (STXBP2)
Ask
View Details MBS1456589-03 0.1 mg (E-Coli)
Recombinant Human Syntaxin-binding protein 2 (STXBP2)
Ask
View Details